- Home
- RARE vs ADX Comparison
RARE vs ADX Comparison
Compare RARE & ADX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RARE
- ADX
- Stock Information
- Founded
- RARE 2010
- ADX 1840
- Country
- RARE United States
- ADX United States
- Employees
- RARE N/A
- ADX N/A
- Industry
- RARE Biotechnology: Pharmaceutical Preparations
- ADX Investment Managers
- Sector
- RARE Health Care
- ADX Finance
- Exchange
- RARE Nasdaq
- ADX Nasdaq
- Market Cap
- RARE 3.1B
- ADX 2.7B
- IPO Year
- RARE 2014
- ADX N/A
- Fundamental
- Price
- RARE $33.28
- ADX $22.67
- Analyst Decision
- RARE Strong Buy
- ADX
- Analyst Count
- RARE 13
- ADX 0
- Target Price
- RARE $87.69
- ADX N/A
- AVG Volume (30 Days)
- RARE 1.5M
- ADX 182.4K
- Earning Date
- RARE 11-03-2025
- ADX 01-01-0001
- Dividend Yield
- RARE N/A
- ADX 6.68%
- EPS Growth
- RARE N/A
- ADX N/A
- EPS
- RARE N/A
- ADX N/A
- Revenue
- RARE $610,159,000.00
- ADX N/A
- Revenue This Year
- RARE $19.72
- ADX N/A
- Revenue Next Year
- RARE $23.29
- ADX N/A
- P/E Ratio
- RARE N/A
- ADX N/A
- Revenue Growth
- RARE 26.77
- ADX N/A
- 52 Week Low
- RARE $25.81
- ADX $14.94
- 52 Week High
- RARE $56.38
- ADX $19.57
- Technical
- Relative Strength Index (RSI)
- RARE 58.42
- ADX 58.33
- Support Level
- RARE $32.40
- ADX $22.35
- Resistance Level
- RARE $34.78
- ADX $22.79
- Average True Range (ATR)
- RARE 1.26
- ADX 0.25
- MACD
- RARE 0.27
- ADX 0.01
- Stochastic Oscillator
- RARE 71.21
- ADX 65.16
About RARE Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. It identifies, acquires, develops, and commercializes novel products for the treatment of serious rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita, Dojolvi and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older. Mepsevii is indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII.
About ADX Adams Diversified Equity Fund Inc.
Adams Diversified Equity Fund Inc is a diversified investment company. It is an internally managed closed-end fund whose investment objectives are the preservation of capital, the attainment of reasonable income from investments, and an opportunity for capital appreciation. It invests a majority of its assets in very liquid S&P 500 stocks, and has broad flexibility in the selection of stocks, but maintains a sector neutral approach. The fund has a diversified equity portfolio which consists of securities of companies from energy, consumer staples, information technology, financials, and other sectors.